Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F11%3A00003155" target="_blank" >RIV/00216208:11120/11:00003155 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.ijcard.2011.05.021" target="_blank" >http://dx.doi.org/10.1016/j.ijcard.2011.05.021</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ijcard.2011.05.021" target="_blank" >10.1016/j.ijcard.2011.05.021</a>

Result language
angličtina
Original language name
Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study
Original language description
This pilot randomized trial assessed the pharmacodynamic efect of clopidogrel up-titration versus standard clopidogrel dose in patient undergoing PCI with high residual platelet reactivity measured with VerifyNow. Compared to standard dose, clipodogrel up-titration reached the effective platelet inhibition in these patients
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
<a href="/en/project/NS9988" target="_blank" >NS9988: Resistance to antiplatelet agents, its etiology and the possibility of its affection</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)